PMDA — authorised 24 March 2014
- Marketing authorisation holder: BRISTOL-MYERS
- Status: approved
PMDA authorised Farxiga on 24 March 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 24 March 2014.
BRISTOL-MYERS holds the Japanese marketing authorisation.